On Thursday, GSK plc (NYSE:GSK) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an ...

Mississauga, Ontario Thursday, November 14, 2024, 09:00 Hrs [IST] ...

With a rich background in brand positioning, Laura brings a wealth of strategic experience partnering with renowned organizations including Keurig Dr Pepper, Nestle, American Cancer Society, Merck, ...

With most myelofibrosis patients becoming anemic over time, Ojjaara's approval represents a significant milestone to improve the outcomes of these patients while also highlighting GSK's commitment ...

ASHG welcomed eight 2024–2026 Human Genetics Scholars who are recognized for their accomplishments and commitment to fostering DEI in human genetics and genomics.

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer.

Increasing the uptake of palliative care may decrease the aggressiveness of end-of-life care, an analysis of ovarian cancer ...

is a member of committees for the National Comprehensive Cancer Network, the Genitourinary Cancers Steering Committee, the American Society of Clinical Oncology–European Society for Medical Oncology, ...

Other study authors reported relationships with the American Society of Transplantation ... Regeneron Pharmaceuticals, GSK, Janssen Biotech, the Louisiana Organ Procurement Organization, Clinical ...

The continent is being drenched in an avalanche of medical disinformation with the aim of undermining western influence ...